1. Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results. (13th February 2018) Authors: Richardson, Paul G.; Bensinger, William I.; Huff, Carol Ann; Costello, Caitlin L.; Lendvai, Nikoletta; Berdeja, Jesus G.; Anderson, Larry D.; Siegel, David S.; Lebovic, Daniel; Jagannath, Sundar; Laubach, Jacob P.; Stockerl‐Goldstein, Keith E.; Kwei, Long; Clow, Fong; Elias, Laurence; Salman, Zee... Journal: British journal of haematology Issue: Volume 180:Number 6(2018) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗